These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


427 related items for PubMed ID: 20093851

  • 1. Antigen-specific immunotherapy against allergic rhinitis: the state of the art.
    Fujimura T, Okamoto Y.
    Allergol Int; 2010 Mar; 59(1):21-31. PubMed ID: 20093851
    [Abstract] [Full Text] [Related]

  • 2. A randomized controlled trial of sublingual immunotherapy for Japanese cedar pollinosis.
    Horiguchi S, Okamoto Y, Yonekura S, Okawa T, Yamamoto H, Kunii N, Sakurai D, Fujimura T, Nakazawa K, Yasueda H.
    Int Arch Allergy Immunol; 2008 Mar; 146(1):76-84. PubMed ID: 18087165
    [Abstract] [Full Text] [Related]

  • 3. [Lowered effectiveness of immunotherapy for cypress pollinosis by using Japanese cedar pollen extract].
    Horiguchi S, Okamoto Y, Yonekura S, Okawa T, Kunii N, Yamamoto H, Sakurai D, Hanazawa T.
    Arerugi; 2008 May; 57(5):558-61. PubMed ID: 18520178
    [Abstract] [Full Text] [Related]

  • 4. Sublingual immunotherapy for Japanese cedar pollinosis.
    Okubo K, Gotoh M.
    Allergol Int; 2009 Jun; 58(2):149-54. PubMed ID: 19390236
    [Abstract] [Full Text] [Related]

  • 5. Cry j 1-induced synthesis of interleukin-5 and interferon-gamma by peripheral blood mononuclear cells of patients with seasonal allergic rhinitis due to Japanese cedar pollens.
    Nakai Y, Ohashi Y, Tanaka A, Kakinoki Y, Washio Y, Masamoto T, Yamada K, Nakai Y, Ohmoto Y.
    Acta Otolaryngol Suppl; 1998 Jun; 538():143-51. PubMed ID: 9879414
    [Abstract] [Full Text] [Related]

  • 6. Preclinical evaluation of an immunotherapeutic peptide comprising 7 T-cell determinants of Cry j 1 and Cry j 2, the major Japanese cedar pollen allergens.
    Hirahara K, Tatsuta T, Takatori T, Ohtsuki M, Kirinaka H, Kawaguchi J, Serizawa N, Taniguchi Y, Saito S, Sakaguchi M, Inouye S, Shiraishi A.
    J Allergy Clin Immunol; 2001 Jul; 108(1):94-100. PubMed ID: 11447388
    [Abstract] [Full Text] [Related]

  • 7. Clinical effects of immunotherapy on Japanese cedar pollinosis in the season of cedar and cypress pollination.
    Ito Y, Takahashi Y, Fujita T, Fukuyama S.
    Auris Nasus Larynx; 1997 Apr; 24(2):163-70. PubMed ID: 9134139
    [Abstract] [Full Text] [Related]

  • 8. Blocking antibody is generated in allergic rhinitis patients during specific immunotherapy using standardized Japanese cedar pollen extract.
    Kawakami A, Koketsu R, Suzukawa M, Nagao M, Hiraguchi Y, Tokuda R, Fujisawa T, Nagase H, Ohta K, Yamamoto K, Yamaguchi M.
    Int Arch Allergy Immunol; 2008 Apr; 146 Suppl 1():54-60. PubMed ID: 18504408
    [Abstract] [Full Text] [Related]

  • 9. [Antigen specific sublingual immunotherapy for pediatric Japanese cedar pollinosis].
    Yuta A, Miyamoto Y, Ogihara H, Hattori R, Okubo K.
    Arerugi; 2009 Feb; 58(2):124-32. PubMed ID: 19329875
    [Abstract] [Full Text] [Related]

  • 10. Sublingual immunotherapy with once-daily grass allergen tablets: a randomized controlled trial in seasonal allergic rhinoconjunctivitis.
    Durham SR, Yang WH, Pedersen MR, Johansen N, Rak S.
    J Allergy Clin Immunol; 2006 Apr; 117(4):802-9. PubMed ID: 16630937
    [Abstract] [Full Text] [Related]

  • 11. Approaches to immunotherapies for Japanese cedar pollinosis.
    Sakaguchi M, Hirahara K, Fujimura T, Toda M.
    Auris Nasus Larynx; 2011 Aug; 38(4):431-8. PubMed ID: 21227607
    [Abstract] [Full Text] [Related]

  • 12. Efficacy of sublingual coseasonal immunotherapy with a monomeric allergoid in Cupressaceae pollen allergy--preliminary data.
    Ariano R, Panzani RC, Mistrello G.
    Eur Ann Allergy Clin Immunol; 2005 Mar; 37(3):103-8. PubMed ID: 15918297
    [Abstract] [Full Text] [Related]

  • 13. Clinical efficacy and safety of sublingual immunotherapy with tree pollen extract in children.
    Valovirta E, Jacobsen L, Ljørring C, Koivikko A, Savolainen J.
    Allergy; 2006 Oct; 61(10):1177-83. PubMed ID: 16942565
    [Abstract] [Full Text] [Related]

  • 14. The effects of grass pollen allergoid immunotherapy on clinical and immunological parameters in children with allergic rhinitis.
    Keskin O, Tuncer A, Adalioglu G, Sekerel BE, Saçkesen C, Kalayci O.
    Pediatr Allergy Immunol; 2006 Sep; 17(6):396-407. PubMed ID: 16925684
    [Abstract] [Full Text] [Related]

  • 15. Safety of sublingual grass pollen immunotherapy after anaphylaxis.
    Nichani JR, de Carpentier J.
    J Laryngol Otol; 2009 Jun; 123(6):683-4. PubMed ID: 18501039
    [Abstract] [Full Text] [Related]

  • 16. Randomized controlled trial of high-dose sublingual immunotherapy to treat seasonal allergic rhinitis.
    Smith H, White P, Annila I, Poole J, Andre C, Frew A.
    J Allergy Clin Immunol; 2004 Oct; 114(4):831-7. PubMed ID: 15480323
    [Abstract] [Full Text] [Related]

  • 17. Peptide immunotherapy for allergic diseases using a rice-based edible vaccine.
    Hiroi T, Takaiwa F.
    Curr Opin Allergy Clin Immunol; 2006 Dec; 6(6):455-60. PubMed ID: 17088651
    [Abstract] [Full Text] [Related]

  • 18. Frequency of sensitization to different pollen groups and results of specific immunotherapy.
    Martín-Gil D, Neffen H, Oehling A.
    Allergol Immunopathol (Madr); 1978 Dec; 6(4):325-32. PubMed ID: 735982
    [Abstract] [Full Text] [Related]

  • 19. Efficacy and safety of sublingual immunotherapy for two seasons in patients with Japanese cedar pollinosis.
    Okamoto Y, Okubo K, Yonekura S, Hashiguchi K, Goto M, Otsuka T, Murata T, Nakao Y, Kanazawa C, Nagakura H, Okawa T, Nakano K, Hisamitsu M, Kaneko S, Konno A.
    Int Arch Allergy Immunol; 2015 Dec; 166(3):177-88. PubMed ID: 25895909
    [Abstract] [Full Text] [Related]

  • 20. [The evaluation of hyposensitization with sugi pollen extracts in patients with nasal allergy to Japanese sugi pollen].
    Ukai K, Amesara R, Masuda S, Nakamato S, Ohkawa C, Okamoto K, Sakakura Y.
    Arerugi; 1994 Feb; 43(2 Pt 1):101-5. PubMed ID: 8147711
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 22.